Effect of Preoperative Oral Carbohydrate Administration in Thoracic Surgery Patients

Non Small Cell Lung Cancer Clinical Trial

— oralcarbohydra  

Official title:

Effect of Preoperative Oral Carbohydrate Administration in Thoracic Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05005091
• Other study ID #: SureyyapasaM
• Status: Completed
• Phase: N/A
• Start date: January 1, 2017
• Est. completion date: April 30, 2018

Study information

• Verified date: August 2021
• Source: Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Preoperative carbohydrate loading has been shown to reduce pre-operative discomfort and postoperative nausea and vomiting. There is no need for prolonged preoperative fasting of the patients, but the traditional approach still continues especially in thoracic surgery patients. For this purpose, we aimed to evaluate the effect of preoperative carbohydrate loading on postoperative morbidity in the patients.

Description:

The study was conducted on 94 patients. The patients in the control group were fasting after midnight. Experimental group patients consumed carbohydrate drink as liquid two hours before the operation. 47 patients were in the control group (A) and 47 patients were in the experimental group (B). The groups were compared in terms of length of hospital and intensive care unit stay, vomiting, gas-stool outlet, postoperative pain conditions (VAS), inflammation parameters, blood glucose, and mobilization time.

SPSS 11.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical analyses. All means were presented with 95% confidence limits. In the empirical analysis, t-test and chi-square test were used. In addition, correlation analysis was used to determine the relationship between fasting time and surgical recovery time.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 94
• Est. completion date: April 30, 2018
• Est. primary completion date: April 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

Stage I-Stage II all operable NSCLC patients -

Exclusion Criteria:

Patients with diabetes mellitus, a history of delayed gastric emptying, severe hepatic or renal failure, or any endocrine disorder that might influence the metabolic parameters were excluded, as were patients requiring urgent or emergent surgery.

-

Related Conditions & MeSH terms

• Fasting
• Non Small Cell Lung Cancer
• Pneumonia
• Postoperative Pneumonia

Intervention

Dietary Supplement:
• Oral carbohydrate
100 ml oral carbohydrate two hours ago preoperatively

Locations

Country	Name	City	State
Turkey	health Science University, Sureyyapa Training and Research Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mobilization time	postoperative mobilization	1 hour